Evidence map›Paper›PMID 38383863›Full record

ArticleThe EMBO journal2024

Hyperacetylated histone H4 is a source of carbon contributing to lipid synthesis.

Evelina Charidemou, Roberta Noberini, Chiara Ghirardi, Polymnia Georgiou, Panayiota Marcou, Andria Theophanous, Katerina Strati, Hector Keun, Volker Behrends, Tiziana Bonaldi and 1 more

Open access · diamondAbstract read
In one paragraph

Article in The EMBO journal, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 8 papers.

0numbers the graph read from it
0cells of the map it votes in
8citing papers in PubMed
2.3field-weighted citation impact, top 12% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

8 citing papers in PubMed, 11 citations in OpenAlex.

  1. Article
  2. Review
  3. Article
  4. Article
  5. Article
  6. Review
  7. Review
  8. Acetyltransferase in cardiovascular disease and aging.The journal of cardiovascular aging · 2024
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors at 4 institutions in 3 countries.

Evelina CharidemouDepartment of Biological Sciences, University of Cyprus, 2109, Nicosia, Cyprus.
Roberta NoberiniDepartment of Experimental Oncology, IEO, European Institute of Oncology IRCCS, 20139, Milan, Italy.
Chiara GhirardiDepartment of Experimental Oncology, IEO, European Institute of Oncology IRCCS, 20139, Milan, Italy.
Polymnia GeorgiouDepartment of Biological Sciences, University of Cyprus, 2109, Nicosia, Cyprus.ORCID http://orcid.org/0000-0003-3171-9993
Panayiota MarcouDepartment of Biological Sciences, University of Cyprus, 2109, Nicosia, Cyprus.
Andria TheophanousDepartment of Biological Sciences, University of Cyprus, 2109, Nicosia, Cyprus.
Katerina StratiDepartment of Biological Sciences, University of Cyprus, 2109, Nicosia, Cyprus.ORCID http://orcid.org/0000-0002-2332-787X
Hector KeunCancer Metabolism & Systems Toxicology Group, Division of Cancer, Department of Surgery and Cancer, Imperial College London, London, UK.
Volker BehrendsSchool of Life and Health Sciences, Whitelands College, University of Roehampton, London, UK.ORCID http://orcid.org/0000-0003-4855-5497
Tiziana BonaldiDepartment of Experimental Oncology, IEO, European Institute of Oncology IRCCS, 20139, Milan, Italy.ORCID http://orcid.org/0000-0003-3556-1265
Antonis KirmizisDepartment of Biological Sciences, University of Cyprus, 2109, Nicosia, Cyprus. kirmizis@ucy.ac.cy.ORCID http://orcid.org/0000-0002-3748-8711
University of Cyprus · CYUniversity of Milan · ITLondon Cancer · GBUniversity of Roehampton · GB

Funding

EC | Horizon Europe | Excellent Science | HORIZON EUROPE Marie Sklodowska-Curie Actions (MSCA) 890750European Proteomics Infrastructure Consortium providing access (EPIC-XS) 0000424European Proteomics Infrastructure Consortium providing access (EPIC-XS) 0000463Research and Innovation Foundation (RIF) EXCELLENCE/0421/0152Research and Innovation Foundation (RIF) EXCELLENCE/0421/0302Research and Innovation Foundation (RIF) EXCELLENCE/0421/0342
6 · The paper itself

Abstract

Histone modifications commonly integrate environmental cues with cellular metabolic outputs by affecting gene expression. However, chromatin modifications such as acetylation do not always correlate with transcription, pointing towards an alternative role of histone modifications in cellular metabolism. Using an approach that integrates mass spectrometry-based histone modification mapping and metabolomics with stable isotope tracers, we demonstrate that elevated lipids in acetyltransferase-depleted hepatocytes result from carbon atoms derived from deacetylation of hyperacetylated histone H4 flowing towards fatty acids. Consistently, enhanced lipid synthesis in acetyltransferase-depleted hepatocytes is dependent on histone deacetylases and acetyl-CoA synthetase ACSS2, but not on the substrate specificity of the acetyltransferases. Furthermore, we show that during diet-induced lipid synthesis the levels of hyperacetylated histone H4 decrease in hepatocytes and in mouse liver. In addition, overexpression of acetyltransferases can reverse diet-induced lipogenesis by blocking lipid droplet accumulation and maintaining the levels of hyperacetylated histone H4. Overall, these findings highlight hyperacetylated histones as a metabolite reservoir that can directly contribute carbon to lipid synthesis, constituting a novel function of chromatin in cellular metabolism.

Indexed as

CarbonHistonesAcetylationAcetyltransferasesAnimalsChromatinHistone AcetyltransferasesLipidsLipogenesisMiceAcetyltransferasesCarbonChromatinHistone AcetyltransferasesHistonesLipidsAcetylationEpigeneticsHistone ReservoirsLipid Metabolism

Identifiers

PMID38383863
PMCPMC10987603
OpenAlexW4392004498

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.